News
LMAT
101.71
+3.12%
3.08
Weekly Report: what happened at LMAT last week (1028-1101)?
Weekly Report · 2d ago
LeMaitre Vascular: The Market Is Catching On To This Dividend Growth Story
Seeking Alpha · 3d ago
LeMaitre Vascular declares $0.16 dividend
Seeking Alpha · 5d ago
LeMaitre Vascular Price Target Raised to $93.00/Share From $90.00 by Oppenheimer
Dow Jones · 5d ago
Oppenheimer Reiterates Outperform on LeMaitre Vascular, Raises Price Target to $93
Benzinga · 5d ago
Apple To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Friday
Benzinga · 5d ago
In-Depth Examination Of 4 Analyst Recommendations For LeMaitre Vascular
Benzinga · 5d ago
LeMaitre to Participate at Upcoming Investor Conferences in November
Barchart · 5d ago
LeMaitre Vascular Is Maintained at Outperform by Barrington Research
Dow Jones · 5d ago
LeMaitre Vascular Price Target Raised to $93.00/Share From $92.00 by Barrington Research
Dow Jones · 5d ago
Barrington Research Maintains Outperform on LeMaitre Vascular, Raises Price Target to $93
Benzinga · 5d ago
Lemaitre Vascular: Strong Financial Performance and Positive Outlook Drive OUTPERFORM Rating
TipRanks · 5d ago
LeMaitre price target raised to $93 from $92 at Barrington
TipRanks · 5d ago
Analysts’ Top Healthcare Picks: Cigna (CI), Lemaitre Vascular (LMAT)
TipRanks · 5d ago
LEMAITRE VASCULAR, INC. <LMAT.O>: OPPENHEIMER RAISES TARGET PRICE TO $93 FROM $90
Reuters · 5d ago
Lemaitre Vascular (LMAT) Gets a Buy from Stifel Nicolaus
TipRanks · 5d ago
Analysts Offer Insights on Healthcare Companies: Cigna (CI), Zymeworks (ZYME) and Lemaitre Vascular (LMAT)
TipRanks · 5d ago
U.S. RESEARCH ROUNDUP-Amazon, IQVIA Holdings, Uber
Reuters · 5d ago
LEMAITRE VASCULAR INC <LMAT.O>: STIFEL RAISES TARGET PRICE TO $100 FROM $95
Reuters · 5d ago
KeyBanc Remains a Hold on Lemaitre Vascular (LMAT)
TipRanks · 5d ago
More
Webull provides a variety of real-time LMAT stock news. You can receive the latest news about Lemaitre Vasculr through multiple platforms. This information may help you make smarter investment decisions.
About LMAT
LeMaitre Vascular, Inc. is a provider of devices, implants, and services for the treatment of peripheral vascular disease. The Company develops, manufactures, and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Its portfolio of product lines is primarily used to treat vascular disease, of which most are used in open vascular surgery and dialysis access. It also offers human vascular and cardiac tissue cryopreservation services. Its principal product lines include anastomotic clips, biologic vascular and dialysis grafts, biologic vascular and cardiac patches, carotid shunts, embolectomy catheters, occlusion catheters, radiopaque marking tape, synthetic vascular and dialysis grafts, and valvulotomes. The Company’s principal biologic offerings include vascular and cardiac patches as well as vascular and dialysis grafts. The Company sells its products and services primarily through a direct sales force.